Pfizer Inc. plans to resume its practice of raising drug prices early next year after bowing to pressure from President Trump over the summer when the company rolled back some increases.

Pfizer, among the world’s biggest drugmakers by sales, won’t be raising prices as much as it has in past years.

It said it would raise the list prices of...